نتایج جستجو برای: carvedilol

تعداد نتایج: 1683  

Journal: :Indian Journal of Pharmaceutical Sciences 2022

The current work involves preparation and evaluation of self-micro emulsifying drug delivery system carvedilol, an nonselective betablocker alpha-1 blocker. Oral self micro-emulsifying Carvedilol were prepared by studying the solubility in different oils, surfactants co-surfactants formulations using mixtures surfactants, cosurfactants various proportions. Based on study, optimised carvedilol w...

Journal: :Journal of the American College of Cardiology 2003
Ryosuke Nishio Tetsuo Shioi Shigetake Sasayama Akira Matsumori

OBJECTIVES This study was designed to examine the effects of carvedilol in a murine model of viral myocarditis induced by encephalomyocarditis virus (EMCV) infection. BACKGROUND Cytokines play an important role in the pathophysiology of viral myocarditis. Catecholamines influence the production of cytokines via beta-adrenergic receptors, suggesting that beta-adrenergic blockers could modulate...

Journal: :Advanced pharmaceutical bulletin 2015
Ravindra Patil Vishal Pande Raju Sonawane

PURPOSE In the present study rapid melt tablets (RMT's) of carvedilol were prepared by using ionotropic-gelated chitosan nanoparticles using a spray-drying method. Carvedilol is beta-adrenergic antagonist and its oral bioavailability is about 25-35% because of first pass metabolism. METHODS The spray-dried microparticles were formulated into RMT's using a wet granulation process. The Formulat...

Journal: :Life sciences 2007
Chunyu Deng Xiyong Yu Sujuan Kuang Wenchang Zhang Zhiling Zhou Kai Zhang Weimin Qian Zhixin Shan Min Yang Shulin Wu Shuguang Lin

Carvedilol is a beta- and alpha(1)-adrenoceptor antagonist. It is widely used in the treatment of cardiovascular diseases including atrial arrhythmias. However, it is unclear whether carvedilol may affect the repolarization currents, transient outward K(+) current (I(to)) and ultra-rapid delayed rectifier K(+) current (I(Kur)) in the human atrium. The present study evaluated effects of carvedil...

Journal: :Pharmacogenomics 2011
Daniel Sehrt Ingolf Meineke Mladen Tzvetkov Senol Gültepe Jürgen Brockmöller

AIMS Carvedilol is an effective treatment in hypertension and chronic heart failure. The medical impact of polymorphisms in CYP2D6 and in the β-adrenergic receptors ADRB1 and ADRB2 on the pharmacokinetics and pharmacodynamics of carvedilol is controversial. METHODS After carvedilol 25 mg was administered to 110 volunteers, concentrations were enantioselectively quantified and effects on resti...

Journal: :Cardiorenal medicine 2015
Mustafa Yılmaz Alp Aydınalp Kaan Okyay Abdullah Tekin Uğur Abbas Bal Nilüfer Bayraktar Aylin Yıldırır Haldun Müderrisoğlu

AIMS Contrast-induced nephropathy (CIN) is one of the most common causes of hospital-acquired acute renal failure. Oxidative stress and vasoconstriction might play key roles in its pathogenesis. In a few experimental models, antioxidant properties of carvedilol have been documented. The aim of this study was to analyze and compare the effects of carvedilol and metoprolol on the development of C...

2017
Aline Luciano Horta Ana Luisa Junqueira Leite G Paula Costa Vivian Paulino Figueiredo André Talvani

Trypanosoma cruzi causes a cardiac infection characterized by an inflammatory imbalance that could become the inciting factor of the illness. To this end, we evaluated the role of carvedilol, a beta-blocker with potential immunomodulatory properties, on the immune response in C57BL/6 mice infected with VL-10 strain of T. cruzi in the acute phase. Animals (n = 40) were grouped: (i) not infected,...

2006
Valery I. Kozlovski Magdalena Lomnicka Stefan Chlopicki

In contrast to classical -adrenoreceptor antagonists, nebivolol and carvedilol possess endothelium-dependent vasorelaxant properties. It has been proposed that nebivolol and carvedilol activate microvascular endothelium into producing NO by the release of extracellular ATP and subsequent stimulation of endothelial P receptors. Here we tested this hypothesis in the coronary circulation of the is...

فال سلیمان, هما, محمدی, افسانه,

Background and Aim: Heart failure is one of the most prevalent diseases with high mortality and disability. Beta blockers are among basic drugs treating the disorder and leading to reduction in cardiovascular mortality, and improvement of symptoms and left ventricular function. Regarding the increasing prevalence of this disease, the present study was carried out to compare carvedilol with meto...

Journal: :British journal of clinical pharmacology 2008
Stefanie Albers Bernd Meibohm Thomas S Mir Stephanie Läer

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Applying in silico tools such as population pharmacokinetic analysis and simulation will help to find adequate dosing strategies and increase the probability of success for a randomized controlled trial. * Up to now, for carvedilol in paediatric patients with congestive heart failure (CHF) the dose has been linearly extrapolated from adults, but the re...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید